SSSCA1 antibody
Quick Overview for SSSCA1 antibody (ABIN7231530)
Target
See all SSSCA1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- SSA27 Polyclonal Antibody
-
Specificity
- The antibody detects endogenous levels of SSA27 protein
-
Purification
- The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen
-
Immunogen
- Synthesized peptide derived from part region of human SSA27 protein
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:5000-1:20000).
-
Comment
-
Primary Antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium Azide as preservative and 50 % Glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
-
- SSSCA1 (Sjogren Syndrome/scleroderma Autoantigen 1 (SSSCA1))
-
Alternative Name
- SSA27
-
Background
- Rabbit Anti-SSA27 Polyclonal Antibody,Sjoegren syndrome/scleroderma autoantigen 1, Autoantigen p27,SSSCA1 (Sjogren Syndrome/Scleroderma Autoantigen 1) is a Protein Coding gene. Diseases associated with SSSCA1 include Sjogren's Syndrome. GO annotations related to SSSCA1 include identical protein binding. This antigen is recognized by a subset of anti-centromere antibodies from patients with scleroderma and/or Sjogren's syndrome. Subcellular localization has not yet been established.,SSA27
-
Molecular Weight
- observerd band 21kDa
-
Gene ID
- 10534
-
UniProt
- O60232
Target
-